cached image

Piero Parchi, MD

Neurology Università di Bologna, Bologna, Italy 
"Piero Parchi"

Mean distance: 17.19 (cluster 28)
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mammana A, Baiardi S, Rossi M, et al. (2024) Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification. Clinical Chemistry and Laboratory Medicine
Bentivenga GM, Mammana A, Baiardi S, et al. (2024) Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathologica. 147: 18
Mastrangelo A, Mammana A, Parchi P. (2023) Tracking neurodegenerative diseases in biofluids: Combining pathology and pathophysiology markers is the way. Cell Chemical Biology. 30: 1340-1342
Gonzalez-Ortiz F, Karikari TK, Bentivenga GM, et al. (2023) Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Mastrangelo A, Vacchiano V, Zenesini C, et al. (2023) Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 24
Carrer T, Bonato G, Sandre M, et al. (2023) Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Bentivenga GM, Baiardi S, Righini L, et al. (2023) Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience. European Journal of Neurology
Bentivenga GM, Baiardi S, Mastrangelo A, et al. (2023) Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias. Alzheimer's Research & Therapy. 15: 150
Abu-Rumeileh S, Halbgebauer S, Bentivenga GM, et al. (2023) High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease. Annals of Clinical and Translational Neurology
Baiardi S, Mammana A, Capellari S, et al. (2023) Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies. Expert Opinion On Therapeutic Targets. 1-14
See more...